DprE1 Inhibitors

DprE1 inhibitors are a class of pharmaceutical compounds that target and inhibit the enzyme DprE1 which is crucial for the survival and replication of Mycobacterium tuberculosis the bacterium responsible for causing tuberculosis (TB) By blocking the activity of DprE1 these inhibitors effectively disrupt the cell wall synthesis of the TB bacteria leading to their death and the potential treatment of TB infections Our company specializes in providing high-quality DprE1 inhibitors for research and pharmaceutical development purposes

Catalog Number	Chemical Name	CAS #	Price
EI-0276	AZ-7371	1494675-86-3	Online Inquiry
EI-0471	BTZ043	1161233-85-7	Online Inquiry
EI-0766	DprE1-IN-2	1615713-87-5	Online Inquiry
EI-1681	PBTZ169	1377239-83-2	Online Inquiry

Application

DprE1 inhibitors are a crucial tool in the fight against tuberculosis a highly infectious and potentially deadly disease By targeting and inhibiting the activity of the DprE1 enzyme these inhibitors disrupt the formation of essential cell wall components in the tuberculosis bacteria leading to their death and preventing the spread of the disease

In addition to their role in tuberculosis treatment DprE1 inhibitors also have potential applications in the development of new antibiotics By targeting a specific metabolic pathway in bacteria these inhibitors offer a promising avenue for combating antibiotic-resistant strains and tackling the growing threat of drug-resistant infections

Furthermore DprE1 inhibitors can be valuable in basic research studies aimed at understanding the intricate mechanisms of bacterial growth and survival By elucidating the role of the DprE1 enzyme in bacterial physiology scientists can uncover new insights into the biology of tuberculosis and potentially identify novel targets for therapeutic intervention

Please note that all services are for research use only. Not intended for any clinical use.

DprE1 Inhibitors